DPC-681 is primarily utilized in the field of medicinal chemistry as a potent inhibitor targeting specific viral enzymes. Its application is significant in the development of antiviral therapies, particularly for combating viral infections that are challenging to treat with conventional medications. Researchers focus on its ability to interfere with viral replication processes, making it a promising candidate for drug formulations aimed at reducing viral load and managing symptoms in patients. Additionally, DPC-681 is studied for its potential use in combination therapies, where it may enhance the efficacy of other antiviral agents, offering a more comprehensive approach to treatment. Its role in preclinical and clinical studies underscores its importance in advancing antiviral research and addressing unmet medical needs in infectious diseases.